Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis

American Journal of Gastroenterology

Volumn 104, Issue 4, 2009, Pages 855-860

  Bangarulingam, Sanjay Y ^a   Gossard, Andrea A ^a   Petersen, Bret T ^a   Ott, Beverly J ^a   Lindor, Keith D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; LEVOFLOXACIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BALLOON DILATATION; BIOPSY; BLEEDING; BLOOD TRANSFUSION; CHOLANGITIS; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MELENA; PANCREATITIS; PERFORATION; PORTAL HYPERTENSION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; CHOLANGITIS, SCLEROSING; FOLLOW UP; GALLBLADDER; HOSPITALIZATION; INCIDENCE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RISK FACTOR; RUPTURE; TRENDS; UNITED STATES;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CHOLANGITIS, SCLEROSING; FEMALE; FOLLOW-UP STUDIES; GALLBLADDER; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MINNESOTA; PANCREATITIS; POSTOPERATIVE HEMORRHAGE; RETROSPECTIVE STUDIES; RISK FACTORS; RUPTURE;

EID: 65449172444     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2008.161     Document Type: Article

References (19)

1. Bambha K, Kim WR, Talwalkar J et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003;125:1364-9.
2. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995;332:924-33.
3. Farrant JM, Hayllar KM, Wilkinson ML et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991;100:1710-7.
4. Kingham JG, Kochar N, Gravenor MB. Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom. Gastroenterology 2004;126:1929-30.
5. MacCarty RL, LaRusso NF, Wiesner RH et al. Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology 1983;149:39-44.
6. Wiesner RH, LaRusso NF. Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology 1980;79:200-6.
7. Talwalkar JA, Angulo P, Johnson CD et al. Cost-minimization analysis of MRC vs. ERCP for the diagnosis of primary sclerosing cholangitis. Hepatology 2004;40:39-45.
8. Moreno Luna LE, Gores GJ. Advances in the diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis. Liver Transpl 2006;12 (11 Suppl 2):S15-9.
9. Stiehl A, Rudolph G, Kloters-Plachky P et al. Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome aF er endoscopic treatment. J Hepatol 2002;36:151-6.
10. Olsson R, Bjornsson E, Backman L et al. Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers. J Hepatol 1998;28:426-32.
11. Pohl J, Ring A, Stremmel W et al. C e role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis. Eur J Gastroenterol Hepatol 2006;18:69-74.
12. Heimbach JK, Gores GJ, Haddock MG et al. Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 2004;24:201-7.
13. Rea DJ, Heimbach JK, Rosen CB et al. Liver transplantation with neoadjuvant chemoradiation is more efective than resection for hilar cholangiocarcinoma. Ann Surg 2005;242:451-8.
14. Andriulli A, Loperfido S, Napolitano G et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007;102:1781-8.
15. Etzel JP, Eng SC, Ko CW et al. Complications aF er ERCP in patients with primary sclerosing cholangitis. Gastrointest Endosc 2008;67:643-8.
16. Lee JG, Schutz SM, England RE et al. Endoscopic therapy of sclerosing cholangitis. Hepatology 1995;21:661-7.
17. van Milligen de Wit AW, van Bracht J, Rauws EA et al. Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis. Gastrointest Endosc 1996;44:293-9.
18. van den Hazel SJ, WolR agen EH, van Buuren HR et al. Prospective risk assessment of endoscopic retrograde cholangiography in patients with primary sclerosing cholangitis: Dutch PSC Study Group. Endoscopy 2000;32:779-82.
19. Ponsioen CY, Lam K, van Milligen de Wit AW e t al. Four years experience with short term stenting in primary sclerosing cholangitis. Am J Gastroenterol 1999;94:2403-7.